ALD#

Related by string. * * *

Related by context. Frequent words. (Click for all words.) 62 linaclotide 61 ISIS # 61 phase IIb 61 INCB# [002] 60 ASA# 60 BAY #-# 60 daclizumab 59 MGCD# [001] 59 NGX# 59 Perifosine 59 CA4P 58 humanized monoclonal antibody 58 oncology indications 58 AP# [003] 58 PLX# 58 Phase 2b trial 58 blinatumomab 57 Phase 2a 57 ARRY 57 clofarabine 57 Phase 2b 57 Phase Ib 57 preclinical 57 eltrombopag 57 talactoferrin 57 Zerenex 57 Atiprimod 57 IMGN# 57 HspE7 57 Debio 57 Phase IIa trial 57 Santhera 56 tivozanib 56 PF # [001] 56 XL# [003] 56 antisense drug 56 Marqibo 56 CoTherix 56 Phase IIa clinical 56 Phase III clinical 56 sapacitabine 56 HGS ETR1 56 ambrisentan 56 antisense drugs 56 Phase 1b 56 Anthera 55 ofatumumab 55 Phase III 55 ONCONASE 55 preclinical studies 55 elesclomol 55 Phase 2b study 55 investigational compound 55 MDV# 55 eculizumab 55 LymphoStat B 55 RNAi therapeutic 55 Phase 2a trial 55 Alpharadin 55 CRx 55 tesetaxel 55 pralatrexate 55 Tranzyme 55 Actemra 55 T DM1 55 milnacipran 55 NUVIGIL 55 Phase IIb clinical 55 Vasovist 55 Cimzia ® 55 Phase IIb 55 CYT# 55 Plexxikon 55 kinase inhibitor 55 Opexa 55 Telaprevir 55 IDX# 55 tamibarotene 54 metastatic renal cell carcinoma 54 Xiaflex 54 Phase 2a clinical 54 ALN RSV# 54 Phase 2b clinical 54 lupus nephritis 54 golimumab 54 mAb 54 relapsing remitting multiple sclerosis 54 Phase IIa 54 FOLOTYN 54 neuropathic pain 54 Ventavis 54 TREANDA 54 perifosine 54 TRIOLEX 54 MLN# 54 carfilzomib 54 BiTE antibody 54 Silence Therapeutics 54 mixed dyslipidemia 54 retigabine 54 Kyowa Hakko Kirin

Back to home page